Study of the Effects of Bronchoalveolar Lavage Liquid in the ARDS on the Functioning of the Neutrophil Polynuclear System
NCT04008225 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42
Last updated 2019-07-08
Summary
Firstly, the study assesses the effect of bronchoalveolar lavage fluid (BAL) from patients in (acute respiratory distress syndrome (ARDS) on the life span of PNNs and on the phagocytosis of apoptotic cells by macrophages and polynuclear neutrophil (PNN).
Then, the effect of an antibody directed against "high-mobility group box 1" protein (HMGB1) and the effect of metformin on efferocytosis are studied.
Conditions
- ARDS, Human
Interventions
- PROCEDURE
-
Bronchoalveolar lavage
Sponsors & Collaborators
-
Rennes University Hospital
lead OTHER
Principal Investigators
-
Jean-Marc TADIE, MD, PhD · University Hospital of Rennes
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-05
- Primary Completion
- 2016-05-05
- Completion
- 2016-05-05
Countries
- France
Study Locations
More Related Trials
-
Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress Syndrome
NCT05330845 ·Status: TERMINATED ·Phase: NA
-
Neutrophil Elastase and Elafin as Prognostic Biomarker for Acute Respiratory Distress Syndrome
NCT02944279 ·Status: COMPLETED
-
Validation and Precision Treatment of Inflammatory Subphenotypes in Acute Respiratory Distress Syndrome: A Multicenter Cohort Study
NCT07289711 ·Status: RECRUITING
-
EVLWI Exhibits Pulmonary and Systemic Permeability in Sepsis Related ALI/ARDS
NCT01694147 ·Status: UNKNOWN
-
Explore Potential Plasma and BALF Immunometabolic and Lipidomic Biomarkers for Identifying ARDS Endotypes
NCT05451342 ·Status: UNKNOWN
-
The Mechanism of Extracellular Vesicles Containing Mitochondrial DNA in ARDS Lung Injury Caused by Extrapulmonary Sepsis
NCT05061212 ·Status: UNKNOWN
-
Evolution of the Lymphocyte Phenotype in Patients with Infection in Intensive Care Unit
NCT06415474 ·Status: RECRUITING ·Phase: NA
-
The Evaluation of NETs, Caspase-1 and Cytokines in ARDS Patients
NCT03227107 ·Status: UNKNOWN
-
Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease
NCT00217880 ·Status: COMPLETED ·Phase: NA
-
Influence of Acute Respiratory Distress Syndrome (ARDS) and Severe Sepsis on sRAGE Levels in ICU Patients
NCT00811629 ·Status: COMPLETED
-
Study of Immunity Dysfunction Induced by Extracorporeal Assistance (ECMO / ECLS)
NCT03262155 ·Status: COMPLETED
-
Bronchoalveolar Lavages for Cytologic Assessment in Intensive Care Unit Patients
NCT03098888 ·Status: COMPLETED
-
ARDS - Clinical Epidemiology and the Role of the Inflammatory Response - SCOR in Acute Lung Injury
NCT00005318 ·Status: COMPLETED
-
Immune Alveolar Alterations During Pneumonia-Associated Acute Respiratory Distress Syndrome
NCT03971006 ·Status: UNKNOWN
-
Measuring Auto-fluorescence of White Corpuscles for the Early Diagnosis and the Monitoring of Pneumonia in ICU
NCT02717767 ·Status: COMPLETED
-
Pilot Study on Cytokine Filtration in COVID-19 ARDS
NCT04361526 ·Status: UNKNOWN ·Phase: NA
-
Understanding the Role of Genes and Biomarkers in the Inflammation and Blood Clotting Process in Children With Acute Lung Injury
NCT00605527 ·Status: COMPLETED
-
Tetracycline to Limit the Innate Immune Response in Acute Respiratory Distress Syndrome
NCT04079426 ·Status: UNKNOWN
-
An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States
NCT06272942 ·Status: COMPLETED
-
Lung Injury Prediction Study
NCT00889772 ·Status: COMPLETED
-
Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients
NCT05115045 ·Status: COMPLETED
-
Single-cell Landscape of BALF in Patients With Severe ARDS and CARDS
NCT05933291 ·Status: COMPLETED
-
Biological Markers to Identify Early Sepsis and Acute Lung Injury
NCT00825357 ·Status: COMPLETED
-
Pulmonary Microbiota and ARDS Mortality
NCT04133558 ·Status: UNKNOWN
-
Changes of Exosomes and Biomarkers in Plasma and Alveolar Lavage Fluid of Patients With Sepsis Complicated With ARDS
NCT05476029 ·Status: UNKNOWN